Neurohypophyseal hormones and brain neurochemistry (Q40093880)

17 September 2017

1 reference

title

Neurohypophyseal hormones and brain neurochemistry (English)

1 reference

17 September 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

14 August 2023

author name string

D. H. Versteeg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6144115

14 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6144115

14 August 2023

publication date

1 January 1982

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0163725882900717?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

https://api.elsevier.com/content/article/PII:0163725882900717?httpAccept=text/plain

14 August 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Pharmacology & Therapeutics

14 August 2023

published in

1 reference

17 September 2017

volume

19

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

297-325

1 reference

Systemically administered prolyl-leucyl-glycinamide fails to alter dopaminergic neuronal activity in the rat brain

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Impaired Learning and Decreased Cortical Norepinephrine after Bilateral Locus Coeruleus Lesions

14 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Vasopressin augments depolarization-induced release and synthesis of serotonin in hippocampal slices.

14 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Potentiation of levodopa effect by intravenous L-prolyl-L-leucyl-glycine amide in man

14 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Differential localization of antigonadotropic and vasotocic activities in bovine and rat pineal

14 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use

14 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes

14 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Immunocytochemical evidence for the presence of arginine vasotocin in the rat pineal gland

14 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Oxytocin biotransformation in the rat limbic brain: characterization of peptidase activities and significance in the formation of oxytocin fragments.

14 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Oxytocin biotransformation in the rat limbic brain: Chemical characterization of two oxytocin fragments and proposed pathway for oxytocin conversion

14 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Extrahypothalamic vasopressin and oxytocin innervation of fetal and adult rat brain

14 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Structural elucidation of a gonadotropin-inhibiting substance from the bovine pineal gland

14 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Isolation and Characterization of a Gonadotropin-Inhibiting Substance from the Bovine Pineal Gland

14 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Suppression of the Preovulatory Surge of Luteinizing Hormone and Subsequent Ovulation in the Rat by Arginine Vasotocin

14 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Antagonism of morphine-induced catalepsy by L-prolyl-L-leucyl-glycinamide

14 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings

14 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Investigations on α-MSH and MIF-I effects on cyclic AMP levels in rat brain

14 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Cortical Synapses and Reinforcement: a Hypothesis

14 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Effects of MIF-I and melatonin on novelty-induced defecation and associated plasma 11-OHCS and brain catecholamines

14 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Mouse brain deoxyglucose uptake after footshock, ACTH analogs, α-MSH, corticosterone or lysine vasopressin

14 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

ACTH1–24 and lysine vasopressin selectively activate dopamine synthesis in frontal cortex

14 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats.

14 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments

14 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

14 August 2023

Peptides and behavior

34

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Long term and short term effects on retention of a conditioned avoidance response in rats by treatment with long acting pitressin and alpha-MSH.

14 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Neurohypophyseal principles and memory

14 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Dissociation of the behavioural and endocrine effects of lysine vasopressin by tryptic digestion

14 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Memory deficit in rats with hereditary diabetes insipidus

14 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Vasopressin and memory consolidation

14 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

H-Pro-[3H]Leu-Gly-NH2: Uptake and Metabolism in Rat Brain

14 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

The distribution of vasopressin and oxytocin in the rat brain

14 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Studies on the presence of vasopressin, oxytocin and vasotocin in the pineal gland, subcommissural organ and fetal pituitary gland: failure to demonstrate vasotocin in mammals

14 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Neurochemical responses of mice to ACTH and lysine vasopressin

14 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Mouse brain tyrosine hydroxylase and glutamic acid decarboxylase following treatment with adrenocorticotrophic hormone, vasopressin or corticosterone

14 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Intraventricular ACTH and vasopressin cause regionally specific changes in cerebral deoxyglucose uptake

14 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Clinical investigations for emotional effects of neuropeptide hormones

14 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

14 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Melanocyte-stimulating-hormone release-inhibiting factor-I and tardive dyskinesia

14 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Measurement of nonapeptides in pineal and pituitary using reversed-phase, ion-pair liquid chromatography with post-column detection by radioimmunoassay

14 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

14 August 2023

Q64870155

53

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Dopamine synthesis: stimulation by a hypothalamic factor

14 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Molecular Variation and Possible Lines Of Evolution of Peptide and Protein Hormones

14 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Vasotocin release into the cerebrospinal fluid of cats induced by luteinizing hormone releasing hormone, thyrotrophin releasing hormone and growth hormone release-inhibiting hormone

14 August 2023

60

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Arginine vasotocin: Effects on open field behavior, whole brain monoamines and plasma corticosterone

14 August 2023

61

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

The effect of vasopressin on the activity of ornithine decarboxylase in rat brain and liver

14 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Peptides and the conversion of [3H]tyrosine to catecholamines: Effects of ACTH-analogs, melanocyte-stimulating hormones and lysine-vasopressin

14 August 2023

64

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease

14 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Possible aminergic mediation of MSH release and of the CNS effects of MSH and MIF-I

14 August 2023

69

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Radioimmunoassayable N-Tyr-MIF-1-like activity in rat brain is increased by pinealectomy.

14 August 2023

70

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

α-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas

14 August 2023

73

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Effects of L-prolyl-L-leucyl-glycine amide (MIF-I) on dopaminergic neurons

14 August 2023

74

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amide

14 August 2023

75

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Striatal dopamine turnover and MIF-I.

14 August 2023

76

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

MIF-I and postsynaptic receptor sites for dopamine

14 August 2023

77

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Role of oxytocin in memory and amnesia

14 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

The involvement of catecholaminergic mechanisms in the behavioural action of vasopressin

14 August 2023

79

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

The effects of vasopressin on memory processes: The role of noradrenergic neurotransmission

14 August 2023

80

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Facilitation of memory consolidation by vasopressin: Mediation by terminals of the dorsal noradrenergic bundle?

14 August 2023

81

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures

14 August 2023

82

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

The Interaction of Posterior Pituitary Neuropeptides with Monoaminergic Neurotransmission: Significance in Learning and Memory Processes

14 August 2023

83

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Hereditary diabetes insipidus in rats. Altered cerebral indolamine and catecholamine metabolism

14 August 2023

84

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Effect on memory processes of anti-vasopressin serum microinjected into the dorsal raphe nucleus: the role of catecholaminergic neurotransmission.

14 August 2023

85

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Microinjection of arginine8-vasopressin antiserum into the dorsal hippocampus attenuates passive avoidance behavior in rats.

14 August 2023

86

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Monamines in brain and urine of rats with hereditary hypothalamic diabetes insipidus

14 August 2023

94

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Development of a radioimmunoassay for Pro-Leu-Gly-NH2 (PLG or MIF-I): evidence that PLG is not present in rat brain.

14 August 2023

98

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Behavioural basis of the dorsal bundle extinction effect

14 August 2023

99

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Evidence for a role of brain noradrenaline in attention and stimulus sampling

14 August 2023

100

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Arginine vasotocin and sleep in the rat

14 August 2023

101

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Central Catecholamine Neuron Systems: Anatomy and Physiology of the Norepinephrine and Epinephrine Systems

14 August 2023

104

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Isolation and structure of hypothalamic MSH release-inhibition hormone

14 August 2023

105

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Failure to detect radioimmunoassayable arginine vasotocin in mammalian pineals

14 August 2023

106

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Isolated removal of hypothalamic or other brain nuclei of the rat

14 August 2023

108

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Inhibition of gonadotrophin by a highly purified pineal peptide and by synthetic arginine vasotocin.

14 August 2023

109

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Evidence of Central Gonadotropin Inhibiting Activity of Arginine Vasotocin in the Female Mouse

14 August 2023

110

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

A gonadotropin inhibiting principle in the pineal of human fetuses. Evidence for its identity with arginine vasotocin.

14 August 2023

111

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Inhibition of Release of Corticotropin Releasing Hormone in Cats by Extremely Small Amounts of Vasotocin Injected into the Third Ventricle of the Brain. Evidence for the Involvement of 5-Hydroxytryptamine-Containing Neurons

14 August 2023

112

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Slow-wave sleep induced in cats by extremely small amounts of synthetic and pineal vasotocin injected into the third ventricle of the brain

14 August 2023

113

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Inhibition of Release of Luteinizing Hormone in the Male Rat by Extremely Small Amounts of Arginine Vasotocin: Further Evidence for the Involvement of 5-Hydroxytryptamine-Containing Neurons in the Mechanism of Action of Arginine Vasotocin

14 August 2023

114

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).

14 August 2023

115

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Oxotremorine Antagonism by a Hypothalamic Hormone, Melanocyte-Stimulating Hormone Release-Inhibiting Factor (MIF)

14 August 2023

116

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Deserpidine Antagonism by a Tripeptide, L-Prolyl-L-Leucylglycinamide

14 August 2023

117

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

DOPA Potentiation in Ablated Animals and Brain Levels of Biogenic Amines in Intact Animals after Prolyl-leucylglycinamide

14 August 2023

118

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Parallel changes in behaviour and hippocampal serotonin metabolism in rats following treatment with desglycinamide lysine vasopressin

14 August 2023

120

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Behavioral and biochemical responses of mice to the intraventricular administration of ACTH analogs and lysine vasopressin

14 August 2023

121

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Evolution of antidiuretic hormones and their functions

14 August 2023

122

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

NEUROSECRETION. X. A RELATIONSHIP BETWEEN THE PARAPHYSIS AND THE PARAVENTRICULAR NUCLEUS IN THE GARTER SNAKE (THAMNOPHIS SP.)

14 August 2023

123

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Desglycyl-8-arginine vasopressin affects regional mouse brain cyclic AMP content.

14 August 2023

124

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Action of posterior pituitary neuropeptides on the nigrostriatal dopaminergic system

14 August 2023

126

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

MIF-1: Effects on norepinephrine, dopamine and serotonin metabolism in certain discrete brain regions

14 August 2023

129

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

The Hypothalamic-Neurohypophysial System of the Rat: Localization and Quantitation of Neurophysin by Light Microscopic Immunocytochemistry in Normal Rats and in Brattleboro Rats Deficient in Vasopressin and a Neurophysin

14 August 2023

130

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

α-MSH and MIF-I effects on serotonin levels and accumulation in various rat brain areas

14 August 2023

131

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

α-MSH and MIF-I effects on cGMP levels in various rat brain regions

14 August 2023

132

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

The effects of Mif-I on in vitro c-GMP production by a particulate rat brain fraction

14 August 2023

133

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Exohypothalamic Axons of the Classic Neurosecretory System and their Synapses

14 August 2023

136

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

14 August 2023

137

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Regional effects of vasopressin on rat brain catecholamine metabolism.

14 August 2023

139

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Arginine8-vasopressin affects catecholamine metabolism in specific brain nuclei.

14 August 2023

140

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Stereotaxic mapping of the monoamine pathways in the rat brain.

14 August 2023

143

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Intraseptal administration of vasopressin and oxytocin affects hippocampal electroencephalogram in rats

14 August 2023

144

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Regional distribution of adrenaline in rat brain.

14 August 2023

145

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Neurohypophyseal principles and memory processes

14 August 2023

147

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Modulation of passive-avoidance behavior of rats by intracerebroventricular administration of antivasopressin serum

14 August 2023

148

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Dorsal hippocampus: A site of action of neuropeptides on avoidance behavior?

14 August 2023

149

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Differential localization of the influence of lysine vasopressin and of ACTH 4-10 on avoidance behavior: a study in rats bearing lesions in the parafascicular nuclei.

14 August 2023

151

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

A radioimmunoassay of vasopressin. A note on pituitary vasopressin content in Brattleboro rats.

14 August 2023

152

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Amygdaloid lesions block the effect of neuropeptides (vasopressin, ACTH4–10) on avoidance behavior

14 August 2023

155

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Fornix transection: Discrimination between neuropeptide effects on attention and memory

14 August 2023

156

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Arginine vasotocin: effects on development of reproductive organs

14 August 2023

161

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Dose-dependent prolactin releasing activity of arginine vasotocin in intact and pinealectomized estrogen-progesterone treated adult male rats

14 August 2023

162

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

H-Pro-[3H]Leu-Gly-NH2: Plasma Profile and Brain Uptake Following Subcutaneous Injection in the Rat

14 August 2023

163

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Interaction of peptides related to ACTH, MSH and β-LPH with neurotransmitters in the brain

14 August 2023

164

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Regional concentrations of noradrenaline and dopamine in rat brain

14 August 2023

165

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Catecholamine concentration and turnover in discrete regions of the brain of the homozygous Brattleboro rat deficient in vasopressin

14 August 2023

166

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Prolyl-leucyl-glycinamide (PLG); regional effects on alpha-MPT-induced catecholamine disappearance in rat brain

14 August 2023

167

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Vasopressin modulates the activity of catecholamine containing neurons in specific brain regions

14 August 2023

168

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Effect of des-Tyr1-gamma-endorphin and des-Tyr1-alpha-endorphin on alpha-MPT-induced catecholamine disappearance in rat brain nuclei: a dose--response study.

14 August 2023

170

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

The evolution of the vertebrate neurohypophysial hormones in relation to the genetic code

14 August 2023

172

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

The effect of somatostatin and of prolyl-leucyl-glycinamide (MIF) on ACTH release in dispersed pituitary cells

14 August 2023

173

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

Production of MSH-release-inhibiting hormone by a particulate preparation of hypothalami: Mechanisms of oxytocin inactivation

14 August 2023

175

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90071-7

14 August 2023

Identifiers

1 reference

17 September 2017

1 reference